ADIPOQ and type 2 diabetes mellitus: These data support studies in mice [33,50,51] and provide correlative evidence suggesting that these components of adipose tissue dysfunction, possibly through reduced secretion of adiponectin, may exert deleterious effects on skeletal muscle protein metabolism, and that these mechanisms might be exaggerated in patients with T2D compared with obesity alone.